SCHEMBL8109166

SCHEMBL8109166

CCCC(F)(F)c1nc(C(C)CC)n(Cc2ccc(Cc3cccc(C(=O)O)c3)cc2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
HDAC6 Q9UBN7 1/20 0.36
PPARG P37231 1/20 0.35
HTT P42858 1/20 0.35
IDO1 P14902 1/20 0.35
TDO2 P48775 1/20 0.35
AGTR2 P50052 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
POLB P06746 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALDH1A1 P00352 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
YTHDC1 Q96MU7 1/20 0.34
TLR8 Q9NR97 1/20 0.34
TLR7 Q9NYK1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9532978 0.90 PPARG (0.46) HDAC6PPARGSMN1; SMN2NPC1RAB9A
SCHEMBL8103507 0.85 TSHR (0.39) CA1CA2CA9AGTR2
SCHEMBL8105392 0.85 AGTR1 (0.40) CA1CA2CA9HDAC6PPARG
SCHEMBL8105326 0.85 CA1 (0.38) CA1CA2CA9PPARGHTT
SCHEMBL8109295 0.85 PPARG (0.37) CA1CA2CA9HDAC6PPARG
SCHEMBL8109183 0.84 PPARG (0.43) CA1CA2CA9PPARGHTT
SCHEMBL8103578 0.84 GRN (0.39) CA1CA2CA9PPARGHTT
SCHEMBL8110981 0.84 CA1 (0.40) CA1CA2CA9HTTIDO1
SCHEMBL8103395 0.83 AGTR1 (0.41) AGTR2
SCHEMBL8109330 0.82 AGTR1 (0.42) AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3098772-B2 2000-10-16 JP claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP claimed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed